Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer Pfizer Inc. announced topline results from the Phase 3 SigVie-002 study (previously known as Be6A Lung-01) evaluating sigvotatug vedotin, an investigational, potential…
BIOTECanada Opens Canada Pavilion at BIO 2026 Amid Major Policy Momentum for Canadian Biotech BIOTECanada officially opened the Canada Pavilion today at the BIO International Convention in San Diego, serving as the central hub for Canadian biotechnology companies to showcase…
Pheno Therapeutics Granted FDA IND Clearance for Lead Multiple Sclerosis Therapeutic Candidate PTD802 Pheno Therapeutics Limited. (Pheno), a clinical stage biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, today announced…
Bionyra Pharma Launches with $165 million Oversubscribed Series A to Advance Clinical Stage Pipeline of Next Generation Biologics for Immune-Mediated Inflammatory Diseases Bionyra Pharma, a clinical-stage biopharmaceutical company developing next-generation biologics for immune-mediated inflammatory diseases, today announced the company’s launch…
Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery Greenstone Biosciences, Inc. announces a collaboration with Intel Corp. to accelerate AI-enabled drug discovery using Greenstone’s large-scale, human biobank of induced pluripotent stem cells and Intel’s Edge AI advanced computing and AI infrastructure. Intel and Greenstone are working together…
New Critique by Haypp Group Warns Seizure Claims About Nicotine Pouches Overstate Animal Study Findings Giving mice a chemically induced epileptic condition and then adding nicotine does not prove that nicotine causes or worsens seizures, according to Haypp Group’srecently published…
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist IQM Quantum Computers, the global leader in superconducting quantum computers, announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés…
101 Therapeutics Releases Clinical Evidence Package for Macrophage-Targeted 101-PGC-005 and Seeks Urgent Independent Review for Bundibugyo Ebola Disease 101 Therapeutics Ltd. today announced the public release of its clinical and scientific evidence package for 101-PGC-005 (‘005), a macrophage-targeted dexamethasone prodrug…
Blooming Future Launches Operations as Part of Braskem’s Expanding Sustainable Fleet Braskem the largest polyolefins producer in the Americas and global leader in the production of biopolymers on an industrial scale announces that Braskem Trading & Shipping (BT&S) has launched the…
Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy Laprophan Group, the pioneer and one of Morocco’s leading pharmaceutical groups, announced the successful completion of the acquisition of a controlling stake in Rivopharm, a Switzerland-based pharmaceutical company specialized in…
Real Chemistry Unifies Omnichannel Offering as Real Chemistry Media, a Technology-led, Healthcare-focused Practice of the Future Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, announced the full integration of…
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress CareDx, Inc. The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value…